Relation of baseline high-sensitivity C-reactive protein level to cardiovascular outcomes with rosuvastatin in the Justification for Use of statins in Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER). (Q38467359)
Jump to navigation
Jump to search
scientific article published on 10 June 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Relation of baseline high-sensitivity C-reactive protein level to cardiovascular outcomes with rosuvastatin in the Justification for Use of statins in Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER). |
scientific article published on 10 June 2010 |
Statements
1 reference
Relation of baseline high-sensitivity C-reactive protein level to cardiovascular outcomes with rosuvastatin in the Justification for Use of statins in Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER). (English)
1 reference
Peter Libby
1 reference
Paul M Ridker
1 reference
Robert J Glynn
1 reference
Jean MacFadyen
1 reference
10 June 2010
1 reference
1 reference
Identifiers
1 reference